Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multi-center Clinical Study on Hemoperfusion of KHA80
Sponsor: First Affiliated Hospital of Fujian Medical University
Summary
To evaluate the decreasing rate of blood IL-6, β2-MG and PTH in maintenance hemodialysis patients in the 52nd week compared with routine hemodialysis.
Official title: Prospective, Multicenter, Randomized, Open Label Study on the Efficacy and Safety of Comparison of KHA80 Blood Perfusion Combined With Hemodialysis and Conventional Hemodialysis in Clearing IL-6, β2-MG and PTH in Maintenance Hemodialysis Patients
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
394
Start Date
2025-01-13
Completion Date
2027-05-31
Last Updated
2025-01-14
Healthy Volunteers
No
Interventions
KHA80 hemoperfusion treatment
On the basis of hemodialysis or hemodiafiltration treatment, Jianfan KHA80 hemoperfusion treatment was given, and the frequency of hemoperfusion treatment was ≥2 times/month.
Locations (1)
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China